
White House withdraws Heidi Overton’s FDA nomination after Republican concerns
The story in brief
The White House has withdrawn Dr. Heidi Overton’s FDA nomination amid Republican concerns, just a day before the Senate Health Committee was set to vote on advancing her nomination. The FDA is still reviewing mifepristone’s safety for a March decision, and Overton’s confirmation prospects are slim with Democrats in control of the Senate in January.